Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe
  • Written by Admin
  • Written date 2019-02-07 09:26:27
  • Inquire 2719

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Conference 2019 (https://www.jpmorgan.com/global/healthcareconference).


List





Prev Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...